The impact of arsenic exposure on DNA methylation in humans: building an epigenetic biomarker of exposure across three independent cohorts

BACKGROUND: Inorganic arsenic (As) is a carcinogen and >200 million people worldwide are exposed to As through drinking water. Long-term As exposure increases the risk of chronic diseases including cancer and cardiovascular disease. While prior work has identified several genomic regions where DNA methylation (DNAm) is associated with As exposure, our knowledge remains limited. METHODS: We first evaluated the association of As exposure (measured in urine and drinking water) with DNAm (measured genome-wide in blood cells at >720 000 cytosine-phosphate-guanine (CpG) sites) among 1186 Bangladeshi adults from the Health Effects of Arsenic Longitudinal Study-a population with a wide range of As exposure levels. We then utilized elastic net regression to build a DNAm-based biomarker of As exposure. RESULTS: We identified 1177 CpGs associated with urinary As (false discovery rate < 0.05) and further demonstrated that these associations are likely causal by using genetic determinants of As metabolism as instrumental variables. Arsenic-associated CpGs showed strong enrichment for genomic context and CpG sets related to disease states previously linked to As exposure. We developed a 255-CpG DNAm-based biomarker of As exposure that was highly predictive of urinary As levels (r2 = 0.46) and arsenical skin-lesion status (area under the receiver-operating characteristic curve = 0.69)-a common sign of As toxicity. This biomarker was also highly associated with measured urinary As levels in an independent Bangladeshi cohort (P = 1.3 × 10-19) and further validated in the Strong Heart Study (P = 6.7 × 10-6), in which the DNAm-predicted As was also associated with overall mortality (P = 4.6 × 10-4). CONCLUSION: We demonstrate the utility of a DNAm-based biomarker of As exposure that can predict the risk of toxicity and present guidelines for developing epigenetic biomarkers to track environmental chemical exposures.

Authors

Institutions

Publication Details

Journal
International Journal of Epidemiology
Published
2026-03-31
DOI
https://doi.org/10.1093/ije/dyag056
Primary Topic
Arsenic contamination and mitigation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of arsenic exposure on DNA methylation in humans: building an epigenetic biomarker of exposure across three independent cohorts

Lizeth I. Tamayo, Lin Chen, Lin Tong, Niyati Jain et al.
International Journal of Epidemiology
Arsenic contamination and mitigation
article

The impact of arsenic exposure on DNA methylation in humans: building an epigenetic biomarker of exposure across three independent cohorts

Lizeth I. Tamayo, Lin Chen, Lin Tong, Niyati Jain, Brandon L. Pierce, Kathryn Demanelis, Anne K. Bozack, Habibul Ahsan, James L Li, Arce Domingo-Relloso, Ana Navas-Acien, Farzana Jasmine, Muhammad G Kibriya
article en

Abstract

BACKGROUND: Inorganic arsenic (As) is a carcinogen and >200 million people worldwide are exposed to As through drinking water. Long-term As exposure increases the risk of chronic diseases including cancer and cardiovascular disease. While prior work has identified several genomic regions where DNA methylation (DNAm) is associated with As exposure, our knowledge remains limited. METHODS: We first evaluated the association of As exposure (measured in urine and drinking water) with DNAm (measured genome-wide in blood cells at >720 000 cytosine-phosphate-guanine (CpG) sites) among 1186 Bangladeshi adults from the Health Effects of Arsenic Longitudinal Study-a population with a wide range of As exposure levels. We then utilized elastic net regression to build a DNAm-based biomarker of As exposure. RESULTS: We identified 1177 CpGs associated with urinary As (false discovery rate < 0.05) and further demonstrated that these associations are likely causal by using genetic determinants of As metabolism as instrumental variables. Arsenic-associated CpGs showed strong enrichment for genomic context and CpG sets related to disease states previously linked to As exposure. We developed a 255-CpG DNAm-based biomarker of As exposure that was highly predictive of urinary As levels (r2 = 0.46) and arsenical skin-lesion status (area under the receiver-operating characteristic curve = 0.69)-a common sign of As toxicity. This biomarker was also highly associated with measured urinary As levels in an independent Bangladeshi cohort (P = 1.3 × 10-19) and further validated in the Strong Heart Study (P = 6.7 × 10-6), in which the DNAm-predicted As was also associated with overall mortality (P = 4.6 × 10-4). CONCLUSION: We demonstrate the utility of a DNAm-based biomarker of As exposure that can predict the risk of toxicity and present guidelines for developing epigenetic biomarkers to track environmental chemical exposures.

International Journal of EpidemiologyVol. 55(3)
Chicago Department of Public Health (US), University of Pittsburgh (US), University of Illinois Chicago (US), University of Chicago (US), Stanford Health Care (US), New York University (US), Columbia University (US), Stanford University (US)
Susan G. Komen, National Institutes of Health, Indian Health Service, National Institute of Environmental Health Sciences
Openalex Percentile: Top 10%
Arsenic contamination and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.